Dr. Filicko-O'Hara

Joanne E. Filicko-O'Hara, MD

Contact Dr. Filicko-O'Hara

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation
  2. Chronic lymphocytic leukemia/small lymphocytic lymphoma with pancytopenia and chylothorax
  3. Testicular lymphoma
  4. Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease
  5. Adenovirus DNA polymerase is recognized by human CD8+T cells
  6. Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: A new paradigm for designer allogeneic blood and marrow transplantation
  7. T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions
  8. Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir
  9. Heterogeneous clearance of antithymocyte globulin after CD34+ -selected allogeneic hematopoietic progenitor cell transplantation
  10. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study
  11. Activity of single-agent melphalan 220-300 mg/m2with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma
  12. Cytoprotection in acute myelogenous leukemia (AML) therapy
  13. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: New approaches to prophylaxis and treatment
  14. Sensorineural hearing loss associated with intrathecal vancomycin
  15. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches
  16. Linezolid in the treatment of vancomycin resistant enterococcus infections in allogeneic stem cell transplant patients